We recently wrote a blog on the opportunity in Next Generation #cancertherapeutics featuring our portfolio company #rakovinatherapeutics 🧬
Check it out and let us know your thoughts👇
https://t.co/c6DQZz7vCh
The market for DDR inhibitors is emerging, and is expected to grow significantly in the coming years 📈 To learn more about DDR Inhibitors, check out our recent blog!
Our new blog post dives into DDR Inhibitors, a class of pharmaceuticals used to treat certain types of cancers, and why investors should be interested. 🧬
https://t.co/c6DQZz83rP
We have published several press releases in the past few months, including presentation and financial information.
Interested? To read more, check out our website!
https://t.co/ElZm78wvac
Taking it back to when our president Mads Daugaard sat down with the Red Thread Ventures team to talk a little more about our 3 research programs. Check out the episode "Biotech Innovation with Mads Daugaard" to learn more! 👏🧬
Very excited to announce our investment in @LevrFinance $1,000,000 pre-seed round!
Levr is a Vancouver based fintech software company transforming the way businesses access and manage loans. 💻 🏦💰
https://t.co/Nr8Y8ly4L8
Rakovina will be presenting at the 6th annual DDR Inhibitors Summit in Boston on January 24th - 26th! Tune in on January 24th at 9:00am EST for a seminar from our President, Mads Daugaard 👏 🧬
In case you missed it, we recently posted a new blog: "Welcoming a New Era of Cancer Therapy"!
Check it out to learn more about the future of #biotech and #pharma, and about some of the amazing work done by @rakovina_rkv ! 👏🧬
https://t.co/yBsT0fZvXi
Happy Holidays from Team Weave VC. Wishing you and your loved ones a wonderful season! See you in 2023🚀👏🎊🎄 #VentureCapital#canadatech
-
https://t.co/ZoBSm0A8tr
Very proud of our portfolio company @rakovina_rkv for doing such important work in the #childhoodcancer space. Keep up the incredible progress!
—
https://t.co/AXvIXV62OS